Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of first-in-class treatments for cancer. It offers different programs for cancer and inflammatory disease patients such as vascular targeting system and Lecinoxoids. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.
SHORT INTEREST
69.52K 08/30/19
P/E Current
-2.01
P/E Ratio (with extraordinary items)
-2.48
Average Recommendation: OVERWEIGHT
Average Target Price: 3.25
SHORT INTEREST
69.52K 08/30/19
P/E Current
-2.01
P/E Ratio (with extraordinary items)
-2.48
Average Recommendation: OVERWEIGHT
Average Target Price: 3.25
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Download our Mobile App >>
Android: dexwirenews.com/APP
Apple: dexwirenews.com/iOS
2) Join our Telegram >> t.me/DEXWireNews
3) Follow @DEXWireNews on Social Media
1) Download our Mobile App >>
Android: dexwirenews.com/APP
Apple: dexwirenews.com/iOS
2) Join our Telegram >> t.me/DEXWireNews
3) Follow @DEXWireNews on Social Media